Literature DB >> 23536016

Prevalence and associations of potentially inappropriate prescriptions in Austrian nursing home residents: secondary analysis of a cross-sectional study.

Eva Mann1, Burkhard Haastert, Birgit Böhmdorfer, Thomas Frühwald, Bernhard Iglseder, Regina Roller-Wirnsberger, Gabriele Meyer.   

Abstract

BACKGROUND: Potentially inappropriate prescriptions (PIP) are an important cause of adverse medication-related events and increases morbidity, hospitalization, and health care costs, especially in nursing home residents. However, little is known about the associations between PIP and residents' characteristics.
OBJECTIVE: The aim of our study was to analyse the prevalence and associations of PIP with residents' and facilities' characteristics.
METHODS: We performed a secondary analysis of a cross-sectional study with 48 out of 50 eligible nursing homes and 1,844 out of 2,005 eligible residents in a defined rural-urban area in Austria. The Austrian list of potentially inappropriate medications was applied for the evaluation of inappropriate prescribing. Cluster-adjusted multiple regression analysis was used to investigate institutional and residents' characteristics associated with PIP.
RESULTS: Mean cluster-adjusted prevalence of residents with at least one PIP was 70.3 % (95 % CI 67.2-73.4). The number of residents with at least one psychotropic PIP was 1.014 (55 %). The most often prescribed PIP were Prothipendyl (25.9 % residents), Lorazepam (14.5 %) and Diclofenac (6.1 %). Multiple regression analysis showed an inverse association of PIP with cognitive impairment and significant positive associations with permanent restlessness and permanent negative attitude. The associations of PIP with age and male gender were inconsistent. No significant associations were found for PIP and the ratio of staff nurses to residents.
CONCLUSIONS: Our study results confirm that PIP is highly prevalent in the nursing home population. These results urgently call for effective interventions. Initiatives and successful interventions performed in other countries could serve as examples for safer prescribing in residents in Austria.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23536016     DOI: 10.1007/s00508-013-0342-2

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  50 in total

1.  Suspected adverse drug events requiring emergency department visits or hospital admissions.

Authors:  R Raschetti; M Morgutti; F Menniti-Ippolito; A Belisari; A Rossignoli; P Longhini; C La Guidara
Journal:  Eur J Clin Pharmacol       Date:  1999-02       Impact factor: 2.953

Review 2.  Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications.

Authors:  A A Mangoni; S H D Jackson
Journal:  Br J Clin Pharmacol       Date:  2004-01       Impact factor: 4.335

Review 3.  Medication-related falls in the elderly: causative factors and preventive strategies.

Authors:  Allen R Huang; Louise Mallet; Christian M Rochefort; Tewodros Eguale; David L Buckeridge; Robyn Tamblyn
Journal:  Drugs Aging       Date:  2012-05-01       Impact factor: 3.923

4.  Nephrotic syndrome and acute tubular necrosis due to meloxicam use.

Authors:  Jorge Vega; Helmuth Goecke; Gonzalo P Méndez; Francisco J Guarda
Journal:  Ren Fail       Date:  2012-09-10       Impact factor: 2.606

5.  Risk factor, age and sex differences in chronic kidney disease prevalence in a diabetic cohort: the pathways study.

Authors:  Margaret K Yu; Courtney Rees Lyles; Luis A Bent-Shaw; Bessie A Young
Journal:  Am J Nephrol       Date:  2012-09-04       Impact factor: 3.754

Review 6.  Management of behavioral problems in Alzheimer's disease.

Authors:  Serge Gauthier; Jeffrey Cummings; Clive Ballard; Henry Brodaty; George Grossberg; Philippe Robert; Constantine Lyketsos
Journal:  Int Psychogeriatr       Date:  2010-01-25       Impact factor: 3.878

7.  Potentially inappropriate medication use and healthcare expenditures in the US community-dwelling elderly.

Authors:  Alex Z Fu; Jenny Z Jiang; Jaxk H Reeves; Jack E Fincham; Gordon G Liu; Matthew Perri
Journal:  Med Care       Date:  2007-05       Impact factor: 2.983

8.  Antipsychotic drug use and mortality in older adults with dementia.

Authors:  Sudeep S Gill; Susan E Bronskill; Sharon-Lise T Normand; Geoffrey M Anderson; Kathy Sykora; Kelvin Lam; Chaim M Bell; Philip E Lee; Hadas D Fischer; Nathan Herrmann; Jerry H Gurwitz; Paula A Rochon
Journal:  Ann Intern Med       Date:  2007-06-05       Impact factor: 25.391

9.  Prevalence of inappropriate medication using Beers criteria in Japanese long-term care facilities.

Authors:  Satoko Niwata; Yukari Yamada; Naoki Ikegami
Journal:  BMC Geriatr       Date:  2006-01-11       Impact factor: 3.921

10.  Inappropriate medication use and risk of falls--a prospective study in a large community-dwelling elderly cohort.

Authors:  Sarah Berdot; Marion Bertrand; Jean-François Dartigues; Annie Fourrier; Béatrice Tavernier; Karen Ritchie; Annick Alpérovitch
Journal:  BMC Geriatr       Date:  2009-07-23       Impact factor: 3.921

View more
  14 in total

1.  Use of nonsteroidal anti-inflammatory drugs and renal failure in nursing home residents-results of the study "Inappropriate Medication in Patients with Renal Insufficiency in Nursing Homes".

Authors:  Michael Dörks; Stefan Herget-Rosenthal; Guido Schmiemann; Falk Hoffmann
Journal:  Wien Klin Wochenschr       Date:  2016-01-12       Impact factor: 1.704

2.  Polypharmacy and potentially inappropriate medications: a cross-sectional analysis among 451 nursing homes in France.

Authors:  Marie Herr; Helene Grondin; Stéphane Sanchez; Didier Armaingaud; Caroline Blochet; Antoine Vial; Philippe Denormandie; Joël Ankri
Journal:  Eur J Clin Pharmacol       Date:  2017-01-16       Impact factor: 2.953

3.  Disparities in the appropriateness of medication use: Analysis of the REasons for Geographic And Racial Differences in Stroke (REGARDS) population-based cohort study.

Authors:  Motiur Rahman; George Howard; Jingjing Qian; Kimberly Garza; Ash Abebe; Richard Hansen
Journal:  Res Social Adm Pharm       Date:  2020-02-20

4.  Polypharmacy, potentially inappropriate medication and cognitive status in Austrian nursing home residents: results from the OSiA study.

Authors:  Reinhard Alzner; Ulrike Bauer; Stefan Pitzer; Maria Magdalena Schreier; Jürgen Osterbrink; Bernhard Iglseder
Journal:  Wien Med Wochenschr       Date:  2016-02-05

Review 5.  Inappropriate Drug Use in People with Cognitive Impairment and Dementia: A Systematic Review.

Authors:  Kristina Johnell
Journal:  Curr Clin Pharmacol       Date:  2015

6.  Inappropriateness of medication prescriptions about chronic kidney disease patients without dialysis therapy in a Chinese tertiary teaching hospital.

Authors:  Ping Yang; Na Chen; Rong-Rong Wang; Lu Li; Sai-Ping Jiang
Journal:  Ther Clin Risk Manag       Date:  2016-10-12       Impact factor: 2.423

7.  Persistent use of psychotropic drugs in nursing home residents in Norway.

Authors:  Anne-Sofie Helvik; Jūratė Šaltytė Benth; Bei Wu; Knut Engedal; Geir Selbæk
Journal:  BMC Geriatr       Date:  2017-02-13       Impact factor: 3.921

8.  Potentially Inappropriate Medication in Community-Dwelling Primary Care Patients who were Screened Positive for Dementia.

Authors:  Diana Wucherer; Tilly Eichler; Johannes Hertel; Ingo Kilimann; Steffen Richter; Bernhard Michalowsky; Jochen René Thyrian; Stefan Teipel; Wolfgang Hoffmann
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

9.  Pain treatment for nursing home residents differs according to cognitive state - a cross-sectional study.

Authors:  Ulrike Bauer; Stefan Pitzer; Maria Magdalena Schreier; Jürgen Osterbrink; Reinhard Alzner; Bernhard Iglseder
Journal:  BMC Geriatr       Date:  2016-06-17       Impact factor: 3.921

10.  Association of potentially inappropriate medications with outcomes of inpatient geriatric rehabilitation : A prospective cohort study.

Authors:  Madeleine Bachmann; Jan Kool; Peter Oesch; Marcel Weber; Stefan Bachmann
Journal:  Z Gerontol Geriatr       Date:  2017-10-25       Impact factor: 1.281

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.